Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?
Glioblastoma multiforme (GBM) represents one of the most frequent malignant brain tumors. Current therapies do not provide real solutions to this pathology. Their failure can be ascribed to a cell subpopulation with stem-like properties called glioma stem cells (GSCs). Therefore, new therapeutic str...
Saved in:
| Main Authors: | Chiara Cilibrasi, Valentina Butta, Gabriele Riva, Angela Bentivegna |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2016/7175067 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNA Methylation Changes during In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability?
by: Angela Bentivegna, et al.
Published: (2013-01-01) -
Prognostic Value of Glioma Cancer Stem Cell Isolation in Survival of Primary Glioblastoma Patients
by: Byung Ho Kong, et al.
Published: (2014-01-01) -
Stem cell therapies and glioma stem cells in glioblastoma: a systematic review of current challenges and research directions
by: Olivier Uwishema, et al.
Published: (2025-08-01) -
Recapitulating Glioma Stem Cell Niches Using 3D Spheroid Models for Glioblastoma Research
by: Hyunji Jo, et al.
Published: (2024-11-01) -
The Effect of Culture on Human Bone Marrow Mesenchymal Stem Cells: Focus on DNA Methylation Profiles
by: Angela Bentivegna, et al.
Published: (2016-01-01)